Michigan Attorney General Dana Nessel secured two settlements with pharmaceutical companies Lannett Company, Inc. and Bausch Health totaling $17.85 million. The settlements address allegations that the companies conspired to manipulate generic drug prices and restrict competition. They follow earlier settlements with Apotex and Heritage totaling $49.1 million and are part of ongoing multistate antitrust litigation, in which Lannett and Bausch have agreed to cooperate with authorities.
Individuals who purchased generic drugs from Lannett or Bausch between May 2009 and December 2019 may be eligible for compensation from these settlements. The state is preparing for a major trial later in 2026 in Hartford, Connecticut. For eligibility details or to file a claim, contact the coalition at 1-866-290-0182 or visit the Attorneys General Generic Drugs Settlement website.
Attorney General Dana Nessel joined a coalition of 42 states in filing a lawsuit against Novartis AG and its subsidiaries Sandoz Group AG and Sandoz AG. The suit accuses the companies of colluding to fix prices and divide the market for 31 generic drugs, with allegations that Novartis fraudulently transferred assets from Sandoz to limit liability in ongoing antitrust litigation. “I am proud of the work my office has done with this multistate coalition to hold drug companies accountable for their role in manipulating prices, reducing competition, and restraining trade in prescriptions,” Nessel said, according to the Michigan Department of Attorney General.
The antitrust accusations are based on extensive investigations involving over 20 million documents and databases containing millions of call records and industry contacts. Evidence shows that the defendants used coded language and met secretly at industry events, dinners, and social gatherings, creating a pattern of collusion and price-fixing that violated antitrust laws and public trust.
The Lannett and Bausch settlements involve a broad coalition of states, highlighting efforts to address unfair practices in the pharmaceutical industry. Consumers who may have overpaid for medication can seek compensation. For details, individuals should contact the coalition through the provided outreach channels.
